Stochter
Profile Picture
European Investor 03 Mar 2026, 05:59
Zoetis Inc. (NYSE: ZTS) has agreed to acquire the animal genomics business of Neogen Corporation (NASDAQ: NEOG) for $160 million, subject to customary adjustments.

The transaction strengthens Zoetis’ Precision Animal Health portfolio by integrating Neogen’s global genomics capabilities, including five laboratories across the U.S., Brazil, Australia, China and the U.K. The business provides fixed array and sequencing technologies, along with software tools that support data-driven breeding and health decisions, and is a leader in U.S. beef and dairy genomics.

Zoetis said the acquisition will enhance predictive insights and individualized care across livestock and companion animals. The deal is expected to close in the second half of 2026, pending regulatory approvals and customary conditions.
Source:Business Wire

Comments

No comments yet.

Ana sayfa